Knockdown of IL-18 gene resulted in reduced arthritic symptoms and decreased pro-inflammatory factors in RA mouse models, and inhibitors of caspase-1 reduced serum concentrations of IL-18 and IL-1β in CIA mice (194). The gene discussed is CASP1; the disease is rheumatoid arthritis.